Aprea Therapeutics, Inc.

... ...
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
PFEPfizer Inc. 0.03%36.710.9%$1161.89m
JNJJohnson & Johnson -0.01%160.280.7%$1077.05m
LLYEli Lilly & Co. 0.01%190.791.1%$703.48m
ABBVAbbVie, Inc. -0.03%110.491.9%$703.16m
MRKMerck & Co., Inc. 0.00%83.380.7%$683.91m
BMYBristol-Myers Squibb Co. 0.03%66.561.0%$677.82m
AZNAstraZeneca Plc 0.00%51.341.2%$630.16m
ARCTArcturus Therapeutics Holdings, Inc. 0.00%59.690.0%$205.25m
VTRSViatris, Inc. 0.00%17.050.0%$192.05m
RPRXRoyalty Pharma Plc 0.00%51.950.2%$173.88m
NVSNovartis AG 0.00%95.630.2%$170.63m
GSKGlaxoSmithKline Plc -0.01%38.470.2%$140.21m
SNYSanofi 0.00%49.390.2%$113.78m
RGENRepligen Corp. 0.00%215.476.9%$75.65m
NVONovo Nordisk A/S 0.00%72.030.1%$70.83m

Company Profile

Aprea Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on developing and commercializing novel cancer therapeutics that reactivate mutant p53 tumor suppressor protein. The company was founded by Vladimir Bykov, Klas Gota Wiman, Staffan Stromblad, Natalia Issaeva, Galina Selivanova, and Wenji Bao in 2002 and is headquartered in Boston, MA.